Highly praised for its ‘top-notch expertise’, the Bristows LLP team regularly advises corporate venturing arms of global multinationals and entrepreneurial businesses in high-profile venture capital transactions. Iain Redford heads the corporate offering, specialising in the life sciences sector, where he chiefly handles investment transactions. The ’technically able’ Marek Petecki is an expert in debt and equity financings. Matt Dennis is knowledgeable in the tech sphere. David Horner is also recommended.
Testimonials
Collated independently by Legal 500 research team.
‘Bristows' team stands out for its top-notch expertise in intellectual property, life sciences, and tech law. They excel in handling high-tech and IP law, especially in growth and early-stage businesses, providing highly customized advice. Their broad skill set combines knowledge from commercial and corporate law, allowing them to tackle complex, multi-party issues effectively.'
- 'Bristows is committed to diversity and inclusion, promoting gender balance and supporting underrepresented groups to create an inclusive workplace - 100% female partners last year is amazing!'
- 'Bristows provides deeper expertise and more customized advice, specializing in their niche areas rather than covering a bit of everything. Clients benefit from a personal touch, with direct access to senior partners and a highly collaborative team, unlike larger, more impersonal firms - especially where they have to follow process that isn't suitable for smaller, fast paced businesses.'
- 'Samuel Munday and David Horner have provided consistently good and appropriate advice - understanding the risks that fast growth businesses need to take.'
‘Good team, work efficiently, know the space.’
‘Marek Patecki very technically able and good at getting to practical solutions.’
Key clients
- Diageo
- Syncona
- Johnson & Johnson Innovations.
- IP Group plc
- Oxford Science Enterprises plc
- Braavos Capital
- Cambridge Innovation Capital
- Francis Crick Institute
- UCL Business
- LifeArc
- Royal Pharmaceutical Society
- Mosaic Therapeutics
- OMass Therapeutics
- ORCA Computing
- Neu Health Digital Ltd
- Ēvolvere Biosciences Ltd
- FundamentalVR
- Oxehealth
- Purespring Therapeutics
- Ultromics Limited
- Dragonfly Media Ltd
- Mironid
- Beacon Therapeutics
- Two Daughters Entertainment Limited
- Aramune Technologies Limited
- Freeline Therapeutics
Work highlights
- Advising Syncona on the £96 million Series A financing of Beacon Therapeutics and the prior merger of Beacon Therapeutics with Applied Genetic Technologies Corporation (AGTC).
- Advising OMass Therapeutics on its £10m Series B extension financing by British Patient Capital.
- Advising Cambridge Innovation Capital and existing client Syncona on a $28m Series A equity investment into Mosaic Therapeutics - a spin-out from the Wellcome Sanger Institute.
Practice head
The lawyer(s) leading their teams.
Iain Redford